LY-487379 hydrochloride
SIGMA/L1170 - ≥98% (HPLC)
Synonym: N-
CAS Number: 353229-59-1
Empirical Formula (Hill Notation): C21H19F3N2O4SHCl
Molecular Weight: 488.91
MDL Number: MFCD11519970
Linear Formula: C21H19F3N2O4SHCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | off-white |
| form | powder |
| InChI | 1S/C21H19F3N2O4S.ClH/c1-2 |
| InChI key | LPWFRDWTOKLHJC-UHFFFAOYSA |
| originator | Eli Lilly |
| Quality Level | 100 ![]() |
| SMILES string | Cl.COc1ccccc1Oc2ccc(cc2)N |
| solubility | DMSO: >20 mg/mL |
| storage condition | desiccated |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | LY-487379 is a positive allosteric modulator of the metabotropic glutamate receptor mGluR2. |
| Biochem/physiol Actions: | LY-487379 is a positive allosteric modulator of the metabotropic glutamate receptor mGluR2. EC50 = 1.7 μM. LY-487379 shows no intrinsic agonist or antagonist activity at hmGluR2 and has no activity at human mGluR3. LY-487379 markedly potentiates glutamate-stimulated [35S]GTPγS binding in a concentration-dependent manner at hmGluR2, shifting the glutamate dose-response curve leftward by 3-fold and increasing the maximum levels of [35S]GTPγS stimulation. LY-487379 has anxiolytic effects in fear-potentiated startle. This activity profile is useful in all symptom domains of schizophrenia. |
| Features and Benefits: | This compound is featured on the Glutamate Receptors (G Protein Family) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Eli Lilly . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352209 |

